Diallyl trisulfide suppresses tumor growth through the attenuation of Nrf2/Akt and activation of p38/JNK and potentiates cisplatin efficacy in gastric cancer treatment
Crossref DOI link: https://doi.org/10.1038/aps.2016.176
Published Online: 2017-03-27
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jiang, Xiao-yan
Zhu, Xiao-song
Xu, Hong-ya
Zhao, Zhong-xi
Li, Si-ying
Li, Shan-zhong
Cai, Jian-hua
Cao, Ji-min
Text and Data Mining valid from 2017-03-27
Article History
Received: 21 July 2016
Accepted: 24 December 2016
First Online: 27 March 2017